新股消息 | 麦科奥特港股IPO及境内未上市股份“全流通”获中国证监会备案

智通财经04-10

智通财经APP获悉，4月10日，中国证监会国际合作司发布《关于陕西麦科奥特医药科技股份有限公司境外发行上市及境内未上市股份“全流通”的备案通知书》。麦科奥特拟发行不超过6676.24万股境外上市普通股并在香港联合交易所上市。公司24名股东拟将所持合计222,016,700股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。招股书显示，麦科奥特为一家生物技术公司，专注于发现、开发及商业化...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2626193511?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-10 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626193511","market":"us","top_or_hot":-1,"title":"新股消息 | 麦科奥特港股IPO及境内未上市股份“全流通”获中国证监会备案","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，4月10日，中国证监会国际合作司发布《关于陕西麦科奥特医药科技股份有限公司境外发行上市及境内未上市股份“全流通”的备案通知书》。麦科奥特拟发行不超过6676.24万股境外上市普通股并在香港联合交易所上市。公司24名股东拟将所持合计222,016,700股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。招股书显示，麦科奥特为一家生物技术公司，专注于发现、开发及商业化...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1427083.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新股消息 | 麦科奥特港股IPO及境内未上市股份“全流通”获中国证监会备案</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新股消息 | 麦科奥特港股IPO及境内未上市股份“全流通”获中国证监会备案\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-10 16:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1427083.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，4月10日，中国证监会国际合作司发布《关于陕西麦科奥特医药科技股份有限公司境外发行上市及境内未上市股份“全流通”的备案通知书》。麦科奥特拟发行不超过6676.24万股境外上市普通股并在香港联合交易所上市。公司24名股东拟将所持合计222,016,700股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。招股书显示，麦科奥特为一家生物技术公司，专注于发现、开发及商业化...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1427083.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1427083.html","article_id":"2626193511","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2626193511","pubTimestamp":1775811247,"columns":[{"name":"新股","id":7,"label_key":null}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，4月10日，中国证监会国际合作司发布《关于陕西麦科奥特医药科技股份有限公司境外发行上市及境内未上市股份“全流通”的备案通知书》。麦科奥特拟发行不超过6676.24万股境外上市普通股并在香港联合交易所上市。公司24名股东拟将所持合计222,016,700股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"91218":"陕西麦科奥特医药科技股份有限公司（临时代码）","BK4588":"碎股","SPCX":"SPAC and New Issue ETF","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard","IPOS":"Renaissance International IPO ETF"},"translate_title":"New stock news | McCoote's Hong Kong IPO and domestic unlisted shares \"full circulation\" were filed by China Securities Regulatory Commission","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91218":1.5,"IPOS":1.5,"VXUS":1.5,"SPCX":1.5},"content_text":"智通财经APP获悉，4月10日，中国证监会国际合作司发布《关于陕西麦科奥特医药科技股份有限公司境外发行上市及境内未上市股份“全流通”的备案通知书》。麦科奥特拟发行不超过6676.24万股境外上市普通股并在香港联合交易所上市。公司24名股东拟将所持合计222,016,700股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。招股书显示，麦科奥特为一家生物技术公司，专注于发现、开发及商业化用于治疗代谢性疾病以及心脑血管疾病的双/多特异性肽类药物。公司已自主开发由一项核心产品及其他六项候选产品组成的产品管线。该公司的核心产品MT1013是全球首创的双靶点受体激动剂多肽药物，可同时靶向CaSR及OGP受体。MT1013主要为治疗SHPT而开发，并计划扩展至包括CKDMBD伴骨质疏松及未接受透析的SHPT在内的额外适应症。附件：“全流通”股东名称及转换数量","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626193511","isCrawlerRequest":true}